TRPV6 (Transient Receptor Potential Cation Channel Subfamily V Member 6), originally discovered as CaT1 (Calcium Transporter 1), encodes a highly calcium-selective ion channel that serves as the primary pathway for calcium absorption in the intestinal epithelium. TRPV6 belongs to the TRPV (Vanilloid) subfamily and is distinguished by its exceptional calcium selectivity, even exceeding that of the related channel TRPV5. Beyond its well-characterized role in epithelial calcium transport, TRPV6 is increasingly recognized for its functions in the central nervous system, where it contributes to neuronal calcium homeostasis, synaptic plasticity, and responses to neurodegenerative stimuli.
TRPV6 is expressed throughout the brain in regions including the hippocampus, cerebral cortex, and basal ganglia, where it participates in calcium-dependent signaling relevant to Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions. The channel's expression in non-neuronal cells including microglia and astrocytes further suggests roles in neuroinflammation and glial function.
| Attribute |
Value |
| Gene Symbol |
TRPV6 |
| Full Name |
Transient Receptor Potential Cation Channel Subfamily V Member 6 |
| Chromosomal Location |
2q37 |
| NCBI Gene ID |
9903 |
| Ensembl ID |
ENSG00000165283 |
| UniProt ID |
Q9H1D0 |
| Protein Length |
725 amino acids |
| Protein Class |
Ion channel, TRPV family |
¶ Molecular Structure and Selectivity
TRPV6 displays the highest calcium selectivity among TRP channels, with a permeability ratio (P_Ca/P_Na) exceeding 100:1. This exceptional selectivity is achieved through:
- Aspartate ring: A conserved aspartate residue (D541) in the pore loop creates a high-affinity calcium binding site
- Single-file conduction: Calcium ions pass through the narrow pore in single file, allowing precise discrimination
- High affinity binding: The channel exhibits nanomolar affinity for calcium, enabling selective conduction despite lower extracellular concentrations
TRPV6 shares the overall architecture of TRPV channels:
- Ankyrin repeat domain (ARD): Six ankyrin repeats at the N-terminus for protein interactions
- Transmembrane domain: Six transmembrane segments (S1-S6) with a pore-forming loop between S5 and S6
- TRP domain: Conserved TRP box motif in the C-terminus involved in gating
TRPV6 is expressed in multiple neuronal populations throughout the brain:
- Hippocampus: High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
- Cerebral cortex: Expressed in pyramidal neurons across cortical layers
- Basal ganglia: Detected in striatal medium spiny neurons and substantia nigra dopaminergic neurons
- Cerebellum: Present in Purkinje cells
TRPV6 is also present in non-neuronal cells of the nervous system:
- Microglia: TRPV6 is expressed in microglial cells where it regulates inflammatory responses
- Astrocytes: Detected in astrocytic cells with upregulation during reactive gliosis
TRPV6 plays important roles in neuronal calcium regulation:
- Calcium entry pathway: Provides a voltage-independent pathway for calcium entry
- Resting calcium: Contributes to maintenance of basal intracellular calcium levels
- Activity-dependent calcium: Mediates calcium influx during specific signaling events
TRPV6 participates in activity-dependent synaptic modification:
- LTP induction: Calcium influx through TRPV6 contributes to long-term potentiation
- LTD mechanisms: Involved in calcium-dependent long-term depression
TRPV6 has been implicated in autophagy regulation in neurons:
- mTOR modulation: TRPV6 activity affects mTOR signaling
- Autophagosome formation: Regulates autophagosome biogenesis
- Protein quality control: Important for clearance of misfolded proteins
TRPV6 dysfunction has been implicated in Alzheimer's disease pathogenesis:
- Calcium dysregulation: Altered TRPV6 expression contributes to neuronal calcium dysregulation in AD
- Amyloid-beta effects: Aβ exposure modulates TRPV6 function and expression
- Synaptic dysfunction: Impaired TRPV6 signaling affects synaptic plasticity and memory
- Autophagy impairment: TRPV6 dysregulation may contribute to impaired autophagic flux in AD
In Parkinson's disease, TRPV6 shows altered expression in vulnerable brain regions:
- Dopaminergic neuron survival: TRPV6 expression is altered in substantia nigra neurons
- Calcium dysregulation: Contributes to calcium dysregulation characteristic of PD
- Oxidative stress: TRPV6-mediated calcium signaling affects oxidative stress responses
TRPV6 plays significant roles in neuroinflammatory processes:
- Microglial activation: TRPV6 in microglia regulates inflammatory cytokine production
- Anti-inflammatory effects: TRPV6 activation can reduce pro-inflammatory responses
TRPV6 is transcriptionally regulated by 1,25-dihydroxyvitamin D3 (calcitriol):
- VDR-mediated: Vitamin D receptor (VDR) directly regulates TRPV6 transcription
- Calcium homeostasis: Vitamin D-dependent regulation coordinates intestinal and neuronal calcium transport
TRPV6 interacts with multiple regulatory proteins involved in calcium homeostasis.
- Calmodulin: Calcium-dependent modulation
- Annexin proteins: Membrane targeting
- VDR: Vitamin D receptor-mediated regulation
- S100A proteins: Calcium-binding interactions
- PDZ domain proteins: Scaffolding complexes
TRPV6 participates in:
- Calcium homeostasis complex (TRPV6 ↔ NCX ↔ PMCA)
- Vitamin D pathway (VDR → TRPV5/6 transcription)
- Autophagy pathway (TRPV6 ↔ mTOR)
- Selectivity filter: Aspartate ring (D541)
- Pore loop between S5 and S6
- Gate region formed by S6 helices
- Six ankyrin repeats for regulation
- Calcium-dependent inactivation
- Calmodulin binding
- PIP2 sensitivity
- Weak voltage dependence
TRPV6 knockout mice show:
- Reduced intestinal calcium absorption
- TRPV5 compensatory upregulation
- Minimal neurological deficits
TRPV6 dysfunction affects:
- Calcium dysregulation
- Autophagy impairment
- Apoptosis pathways
- Neuroinflammation
- Oxidative stress
- Neuronal vulnerability
- Protein aggregate accumulation
- Synaptic dysfunction
- Reactive gliosis
Beyond basic interactions, TRPV6 forms complexes with additional proteins:
- NCX (Na+/Ca2+ exchanger): Calcium extrusion partner
- PMCA: Plasma membrane calcium ATPase
- Annexin family: Membrane targeting and localization
- S100A10/A2: Calcium-binding protein interactions
- VDR: Transcriptional regulation
TRPV6 participates in neuronal calcium homeostasis:
Spatial aspects: TRPV6 contributes to calcium signaling in dendritic compartments.
Temporal dynamics: Channel kinetics shape calcium transients.
Network integration: Works with VGCC, NMDA receptors, and internal stores.
The VDR-TRPV6 connection is clinically significant:
- VDR binds VDRE in TRPV6 promoter
- Calcitriol increases TRPV6 transcription
- Effects on intestinal and neuronal calcium transport
Deficiency states may affect neuronal calcium regulation.
TRPV6 has unique role in autophagy:
- mTOR modulation: TRPV6 activity affects mTOR signaling pathway
- Autophagosome formation: Regulates autophagosome biogenesis
- Lysosomal coordination: Works with lysosomal calcium signaling
- Protein quality control: Important for aggregate clearance
This makes TRPV6 particularly relevant to neurodegenerative diseases.
TRPV6 mutations are associated with:
Cancer overexpression:
- Prostate, breast, pancreatic cancers
- Diagnostic and prognostic marker
- Therapeutic target potential
Neurological implications:
- Altered expression in AD and PD
- Calcium dysregulation role
- Research ongoing
TRPV6 modulators face specific challenges:
Agonists:
- Need for selective activators
- CNS penetration requirements
- Safety considerations
Antagonists:
- Cancer therapeutic potential
- Selectivity over TRPV5
- Dosing strategies
Electrophysiology:
- Patch clamp techniques
- Single-channel recordings
- Biophysical characterization
Molecular approaches:
- CRISPR manipulation
- Reporter assays
- Protein interaction studies
Imaging:
- Calcium imaging
- Live cell microscopy
- FRET sensors
TRPV6 evolutionary features:
Species conservation:
- Highly conserved across vertebrates
- Functional orthologs in all mammals
- Some species variations in regulation
TRPV5 vs TRPV6:
- 75% amino acid sequence identity
- Different tissue expression patterns
- Can form heteromeric channels
- Similar biophysical properties
Selectivity mechanism:
- Aspartate ring similar to TRPV5
- High calcium selectivity maintained
- Pore structure conserved
Cancer biology:
- Overexpression in 90%+ prostate cancers
- Breast cancer prognostic marker
- Pancreatic cancer therapeutic target
- Promotes cell proliferation and survival
Prostate cancer mechanisms:
- Anti-apoptotic signaling
- Enhanced calcium influx
- Cell cycle progression
- Metastasis support
Neurological disease links:
- Altered expression in AD models
- Changes in PD substantia nigra
- Multiple sclerosis demyelination
- Possible therapeutic target
Clinical development status:
- No FDA-approved TRPV6 modulators yet
- Multiple compounds in preclinical development
- Focus on oncology applications
- CNS-penetrant versions being optimized
Challenges:
- Selectivity over TRPV5
- Off-target effects
- Species differences
- Dosing and formulation
Cell models:
- Prostate cancer cell lines
- Neuronal culture systems
- Microglial cultures
- iPSC-derived neurons
Animal models:
- Knockout mice characterization
- Xenograft models
- Transgenic overexpression
- Neurological injury models
Ongoing research:
- Biomarker studies in cancer
- Expression correlation studies
- Therapeutic intervention trials
- Pharmacokinetic studies
Future directions:
- Personalized medicine approaches
- Combination therapies
- Diagnostic development
- Theranostic applications
TRPV6 encodes a highly calcium-selective ion channel originally characterized for its role in intestinal calcium absorption. In the brain, TRPV6 contributes to neuronal calcium homeostasis, synaptic plasticity, and autophagy regulation. Dysregulated TRPV6 function has been implicated in Alzheimer's disease, Parkinson's disease, and neuroinflammatory conditions. The channel represents a potential therapeutic target for neurodegeneration.